Great news from Sepura (SEPU) this morning as the rollercoaster deal with Hytera continues with the announcement that the UK government seem minded to allow the deal to proceed. Just the pesky Germans to deal with now. I feel the skills of Dean Gunnarson are needed now. Who’s Dean Gunnarson you might ask, quite understandably. Well, read on….

Even here, half way up a Greek mountain in the snakefields, word reaches me of a major fundraising being undertaken at 1p by UK Oil & Gas (UKOG).

Hello Share Moochers. After I commended IQE (IQE) the shares have gradually improved, now by some 200%. I very much considered taking profits. Only one thing stopped me last week: the thought that surely some predator had the Cardiff company in its sights. I’m now glad I didn’t sell for a different, more tangible, reason. The case to buy more shares gets better.

A “Significant Project Completion” announcement sees shares in MediaZest (MDZ) currently around 30% higher on the day. Oh, it’s a “Non-regulatory”, RNS Reach ramparoonie (Oops, sorry) ‘announcement’…

“Eckoh plc (ECK), the global provider of secure payment products and customer contact solutions, today issues a trading update for the year ended 31 March 2017. The board of the company confirms that trading for the year ended 31 March 2017 was comfortably in line with market expectations”. Hmmm, what about the September announcement that “it is expected that the company's pre-tax profits for the year to 31 March 2017 will be below market expectations and is expected to be in line with the performance last year” though?...

Advanced Oncotherapy (AVO) has announced that NED and highly respected senior clinical oncologist at Great Ormond St and Barts Dr Nick Plowman “will” invest £250,000 in the company – at 30p a share, a 36% premium to last week’s close. Why am I not convinced that this morning’s announcement is anything other than the most desperate of spoofs in a long line of spoofs here?

Palisade has been a perma bull of gold. We think that its target for the yellow metal is er..optimistic. But we are bulls and anyone without material gold exposure - c15% - is, in our view, bonkers. Anyhow from Palisade a reminder of the bull case.

Presently the markets are blissfully ignorant of the threat that imminent global central bank tightening poses on risky highly valued assets. Despite the market’s current perceived calm facade and low perception of risk, the vast chasm that lies between perceived risk and reality is greater than ever before.

It's congratulations to a longtime poster, first-time winner whose contributions have been almost exclusively on ShareProphets.

I wrote about the rather unexciting merger between Schoold and Lingo Media that FastForward Innovations (FFWD) announced in March (HERE) but with Lingo Media recently issuing its full year results, I felt it merited an update. They don’t make great reading and I’m beginning to wonder whether the deal will actually go ahead.

In days gone by when smaller companies on AIM wanted ro raise cash they went to City brokers and offered them shares at a huge discount with private investors locked out. It was wrong and it was unfair. But all that has changed with Primary Bid.

I have been a fan of Randgold Resources (RRS) for a long time and the latest update from the company continues to support my bullish view here.

Old-time Labour voters have been moving to the Tories by the thousands over Brexit. What is it that they are truly concerned about?

Hello Share Gatherers. Totally (TLY) is a smallish healthcare company I think I've deserted too quickly. And now, even though I am no longer a shareholder, I still think this is a reasonable punt.

There has been much merriment in the bear community recently with the spectacle of short seller Marc Cohodes more or less single-handedly exposing the shenanigans at Toronto listed sub-prime lender Home Capital Group on his twitter feed. The debacle has now become main stream news in Canada and Marc has attained a kind of rock star status amongst his burgeoning army of followers.

This was a done deal for ages but now it has been formalised. It's another box tick to building the mine at Tulu Kapi...

Noting recent coverage of AIM-listed Eden Research (EDEN) and its, ahem, “interesting” funding arrangements with Terpenetech here on ShareProphets I have a question: given that it appears that Eden is the only holder of paid-up shares in Terpenetech, does that not mean that Eden holds the only (currently) valid voting rights? And if that is the case, is not Eden in fact the ultimate controlling party? And if that is the case, should Terpenetech be viewed as a 100% owned and controlled entity of Eden - a subsidiary, therefore, and have to release full audited accounts?

ShareProphets readers don't expect an immediate implosion on Advanced Oncotherapy (AVO). They're leaving it to Father Christmas to do the job. We asked you when the shares would hit 0p - you said!

1Spatial (SPA) is a spatial data and IT managed services-focused company the team here has followed for a while. The shares rose from sub 2p in 2012 to reach more than 10p in early 2014, before sliding back to circa 5p in 2016 - and declining further post an 18^th October announcement of results for the half year ended 31^st July 2016. However, since early March a share price recovery has been in progress – and we are confident that there is more to come from here…

AIM-listed Advanced Oncotherapy (AVO) has a calendar year-end and as such its six-month deadline to publish accounts falls on 30 June – the end of next month. That means getting an audit done which will involve, amongst other things, agreeing the Going Concern statement. Yesterday’s share price plunge might have more than a small bearing on how conversations go in that regard.